ARCHIVES

Combined analysis moves Herceptin to adjuvant setting in breast cancer.

This article is from The Cancer Letter archive.

Vol. 31 No. 21 | May 27, 2005

Download PDF Visit The Full Archive

Related Articles

Emory Stops Patient Accrual After Discovering Problems In Management

June 26, 2009

Beefed Up Centers Subcommittee Meets On Core Guidelines

December 2, 1977

AZT, DDC Combination Increase CD4 Counts, NIAID Trial Finds

January 17, 1992

Obama’s Virtual Colonoscopy Sets Off Real-World Turf War Of Specialty Groups.

March 5, 2010

NCI Says. President Bush Visits NIH, Marks Decline In U.S. Cancer Deaths For Second Year.

January 19, 2007

ACS Endorses Clinton Health Care Reform, Wit qualifications

March 11, 1994